ARCHIVES

NCI Advisors Discuss Cap On Center Core Grants While Broder Complains Cap Is ‘Anti-Intellectual’

This article is from The Cancer Letter archive.

Vol. 17 No. 20 | May 17, 1991

Download PDF Visit The Full Archive

Related Articles

In Brief: Karen Antman And John Glick lead ASCO; ODAC to Meet June 7 On Tamoxifin Trial

May 27, 1994

Text of PDQ Statement on Breast Screening

September 17, 1993

Iressa May Benefit Some Breast Cancer, Studies Find

December 27, 2002

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

May 22, 1981

FDA says official spoke on own behalf in admonition to The Cancer Letter. Association of Health Care Journalists asks FDA official to rescind her rebuke.

March 18, 2005

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

September 12, 2014